HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints/Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vanderbyl, S. Articles by Perkins, E. Search for Related Content PubMed PubMed Citation Articles by Vanderbyl, S. Articles by Perkins, E.

Transfer and Stable Transgene Expression of a Mammalian Artificial Chromosome into Bone Marrow-Derived Human Mesenchymal Stem Cells

Chromos Molecular Systems Inc., Burnaby, British Columbia, Canada

Key Words. Mammalian artificial chromosomes • ACEs • Gene therapy • Cell therapy • Mesenchymal stem cells

Sandra Vanderbyl, MSc, Chromos Molecular Systems Inc., 8081 Lougheed Highway, Burnaby, British Columbia, Canada V5A 1W9. Telephone: 604-415-7100; Fax: 604-415-7151; e-mail: svanderbyl{at}chromos.com

Mammalian artificial chromosomes (ACEs) transferred to autologous adult stem cells (SCs) provide a novel strategy for the ex vivo gene therapy of a variety of clinical indications. Unlike retroviral vectors, ACEs are stably maintained, autonomous, and nonintegrating. In this report we assessed the delivery efficiency of ACEs and evaluated the subsequent differentiation potential of ACE-transfected bone marrow-derived human mesenchymal stem cells (hMSCs). For this, an ACE carrying multiple copies of the red fluorescent protein (RFP) reporter gene was transferred under optimized conditions into hMSCs using standard cationic transfection reagents. RFP expression was detectable in 11% of the cells 4–5 days post-transfection. The RFP-expressing hMSCs were enriched by high-speed flow cytometry and maintained their potential to differentiate along adipogenic or osteogenic lineages. Fluorescent in situ hybridization and fluorescent microscopy demonstrated that the ACEs were stably maintained as single chromosomes and expressed the RFP transgenes in both differentiated cultures. These findings demonstrate the potential utility of ACEs for human adult SC ex vivo gene therapy.

This article has been cited by other articles:

				K. Sudo, M. Kanno, K. Miharada, S. Ogawa, T. Hiroyama, K. Saijo, and Y. Nakamura Mesenchymal Progenitors Able to Differentiate into Osteogenic, Chondrogenic, and/or Adipogenic Cells In Vitro Are Present in Most Primary Fibroblast-Like Cell Populations Stem Cells, July 1, 2007; 25(7): 1610 - 1617. [Abstract] [Full Text] [PDF]

				X. Ren, M. Katoh, H. Hoshiya, A. Kurimasa, T. Inoue, F. Ayabe, K. Shibata, J. Toguchida, and M. Oshimura A Novel Human Artificial Chromosome Vector Provides Effective Cell Lineage-Specific Transgene Expression in Human Mesenchymal Stem Cells Stem Cells, October 1, 2005; 23(10): 1608 - 1616. [Abstract] [Full Text] [PDF]

				M. Lindenbaum, E. Perkins, E. Csonka, E. Fleming, L. Garcia, A. Greene, L. Gung, G. Hadlaczky, E. Lee, J. Leung, et al. A mammalian artificial chromosome engineering system (ACE System) applicable to biopharmaceutical protein production, transgenesis and gene-based cell therapy Nucleic Acids Res., December 7, 2004; 32(21): e172 - e172. [Abstract] [Full Text] [PDF]